Evidence map›Paper›PMID 27822199›Full record

ArticleFrontiers in neurology2016

Clinical Subgroups in Bilateral Meniere Disease.

Lidia Frejo, Andres Soto-Varela, Sofía Santos-Perez, Ismael Aran, Angel Batuecas-Caletrio, Vanesa Perez-Guillen, Herminio Perez-Garrigues, Jesus Fraile, Eduardo Martin-Sanz, Maria C Tapia and 8 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 5 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 5 syntheses or guidelines pooled it, 130 citations in OpenAlex.

  1. A Systematic Review on the Role of the Stria Vascularis in Menière's Disease Pathogenesis.Journal of the Association for Research in Otolaryngology : JARO · 2025
    Pooled it
  2. Suicidal Ideation, Behaviors, and Deaths in People With Ménière's Disease: A Systematic Review.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2025
    Pooled it
  3. The effect of vestibular rehabilitation in Meniere's disease: a systematic review and meta-analysis of clinical trials.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2023
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Menière's disease clinical subtypes and baseline characteristics in a Dutch patient cohort.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  7. Article
  8. Review
  9. The Impact of Genetic Factors in Ménière's Disease.International journal of molecular sciences · 2026
    Review
  10. Article
  11. Dual-target corticosteroid therapy for refractory Ménière's disease: influence of vestibular aqueduct patency and endotypes.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 14 institutions in 2 countries.

Lidia FrejoOtology and Neurotology Group CTS495, Department of Genomic Medicine - Centro de Genómica e Investigación Oncológica - Pfizer/Universidad de Granada/Junta de Andalucía (GENYO) , Granada , Spain.
Andres Soto-VarelaDepartment of Otorhinolaryngology, Division of Otoneurology, Complexo Hospitalario Universitario , Santiago de Compostela , Spain.
Sofía Santos-PerezDepartment of Otorhinolaryngology, Division of Otoneurology, Complexo Hospitalario Universitario , Santiago de Compostela , Spain.
Ismael AranDepartment of Otolaryngology, Complexo Hospitalario de Pontevedra , Pontevedra , Spain.
Angel Batuecas-CaletrioDepartment of Otolaryngology, Hospital Universitario Salamanca , Salamanca , Spain.
Vanesa Perez-GuillenDepartment of Otorhinolaryngology, Hospital Universitario La Fe , Valencia , Spain.
Herminio Perez-GarriguesDepartment of Otorhinolaryngology, Hospital Universitario La Fe , Valencia , Spain.
Jesus FraileDepartment of Otolaryngology, Hospital Miguel Servet , Zaragoza , Spain.
Eduardo Martin-SanzDepartment of Otolaryngology, Hospital Universitario de Getafe , Getafe , Spain.
Maria C TapiaDepartment of Otorhinolaryngology, Instituto Antolí Candela , Madrid , Spain.
Gabriel TrinidadDepartment of Otorhinolaryngology, Division of Otoneurology, Complejo Hospitalario Badajoz , Badajoz , Spain.
Ana María García-ArumiDepartment of Otorhinolaryngology, Hospital Universitario Vall d'Hebron , Barcelona , Spain.
Rocío González-AguadoDepartment of Otorhinolaryngology, Hospital Universitario Marqués de Valdecilla , Santander, Cantabria , Spain.
Juan M Espinosa-SanchezOtology and Neurotology Group CTS495, Department of Genomic Medicine - Centro de Genómica e Investigación Oncológica - Pfizer/Universidad de Granada/Junta de Andalucía (GENYO), Granada, Spain; Department of Otorhinolaryngology, Hospital San Agustin, Linares, Jaen, Spain.
Pedro MarquesDepartment of Otorhinolaryngology, Centro Hospitalar de São João, EPE, University of Porto Medical School , Porto , Portugal.
Paz PerezDepartment of Otorhinolaryngology, Hospital Cabueñes , Gijón , Spain.
Jesus BenitezDepartment of Otolaryngology, Hospital Universitario de Gran Canaria Dr. Negrin , Las Palmas , Spain.
Jose A Lopez-EscamezOtology and Neurotology Group CTS495, Department of Genomic Medicine - Centro de Genómica e Investigación Oncológica - Pfizer/Universidad de Granada/Junta de Andalucía (GENYO), Granada, Spain; Department of Otolaryngology, Instituto de Investigación Biosanitaria ibs.GRANADA, Complejo Hospitalario Universidad de Granada (CHUGRA), Granada, Spain.
Complexo Hospitalario Universitario A Coruña · ESHospital Universitari i Politècnic La Fe · ESPfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research · ESCentro de Implantología Cirugía Oral y Maxilofacial · ESComplejo Hospitalario de Pontevedra · ESComplejo Hospitalario de Salamanca · ESHospital Universitario De Cabueñes · ESHospital Universitario de Getafe · ESHospital Universitario de Gran Canaria Doctor Negrín · ESHospital Universitario Miguel Servet · ESMarqués de Valdecilla University Hospital · ESUniversidad de Granada · ESUniversidade do Porto · PTVall d'Hebron Hospital Universitari · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Meniere disease (MD) is a heterogeneous clinical condition characterized by sensorineural hearing loss, episodic vestibular symptoms, and tinnitus associated with several comorbidities, such as migraine or autoimmune disorders (AD). The frequency of bilateral involvement may range from 5 to 50%, and it depends on the duration of the disease. We have performed a two-step cluster analysis in 398 patients with bilateral MD (BMD) to identify the best predictors to define clinical subgroups with a potential different etiology to improve the phenotyping of BMD and to develop new treatments. We have defined five clinical variants in BMD. Group 1 is the most frequently found, includes 46% of patients, and is defined by metachronic hearing loss without migraine and without AD. Group 2 is found in 17% of patients, and it is defined by synchronic hearing loss without migraine or AD. Group 3, with 13% of patients, is characterized by familial MD, while group 4, that includes 12% of patients, is associated by the presence of migraine in all cases. Group 5 is found in 11% of patients and is defined by AD. This approach can be helpful in selecting patients for genetic and clinical research. However, further studies will be required to improve the phenotyping in these clinical variants for a better understanding of the diverse etiological factors contributing to BMD.

Indexed as

autoimmune disorderscluster analysishearing lossinner earMeniere’s diseasemigrainetinnitusvestibular disorders

Identifiers

PMID27822199
PMCPMC5075646
OpenAlexW2534860566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.